302 related articles for article (PubMed ID: 20061153)
1. p53 and stem cells: new developments and new concerns.
Zhao T; Xu Y
Trends Cell Biol; 2010 Mar; 20(3):170-5. PubMed ID: 20061153
[TBL] [Abstract][Full Text] [Related]
2. The senescence-related mitochondrial/oxidative stress pathway is repressed in human induced pluripotent stem cells.
Prigione A; Fauler B; Lurz R; Lehrach H; Adjaye J
Stem Cells; 2010 Apr; 28(4):721-33. PubMed ID: 20201066
[TBL] [Abstract][Full Text] [Related]
3. Multiple roles of p53-related pathways in somatic cell reprogramming and stem cell differentiation.
Yi L; Lu C; Hu W; Sun Y; Levine AJ
Cancer Res; 2012 Nov; 72(21):5635-45. PubMed ID: 22964580
[TBL] [Abstract][Full Text] [Related]
4. The emerging role of p53 in stem cells.
Bonizzi G; Cicalese A; Insinga A; Pelicci PG
Trends Mol Med; 2012 Jan; 18(1):6-12. PubMed ID: 21907001
[TBL] [Abstract][Full Text] [Related]
5. Induced pluripotent stem cells (iPSCs)--a new era of reprogramming.
Kang L; Kou Z; Zhang Y; Gao S
J Genet Genomics; 2010 Jul; 37(7):415-21. PubMed ID: 20659705
[TBL] [Abstract][Full Text] [Related]
6. Ectopic mTERT expression in mouse embryonic stem cells does not affect differentiation but confers resistance to differentiation- and stress-induced p53-dependent apoptosis.
Lee MK; Hande MP; Sabapathy K
J Cell Sci; 2005 Feb; 118(Pt 4):819-29. PubMed ID: 15687103
[TBL] [Abstract][Full Text] [Related]
7. Rem2 GTPase maintains survival of human embryonic stem cells as well as enhancing reprogramming by regulating p53 and cyclin D1.
Edel MJ; Menchon C; Menendez S; Consiglio A; Raya A; Izpisua Belmonte JC
Genes Dev; 2010 Mar; 24(6):561-73. PubMed ID: 20231315
[TBL] [Abstract][Full Text] [Related]
8. p53 regulates the self-renewal and differentiation of neural precursors.
Armesilla-Diaz A; Bragado P; Del Valle I; Cuevas E; Lazaro I; Martin C; Cigudosa JC; Silva A
Neuroscience; 2009 Feb; 158(4):1378-89. PubMed ID: 19038313
[TBL] [Abstract][Full Text] [Related]
9. Generation and genetic modification of induced pluripotent stem cells.
Schambach A; Cantz T; Baum C; Cathomen T
Expert Opin Biol Ther; 2010 Jul; 10(7):1089-103. PubMed ID: 20528610
[TBL] [Abstract][Full Text] [Related]
10. p53 suppresses the self-renewal of adult neural stem cells.
Meletis K; Wirta V; Hede SM; Nistér M; Lundeberg J; Frisén J
Development; 2006 Jan; 133(2):363-9. PubMed ID: 16368933
[TBL] [Abstract][Full Text] [Related]
11. [Tumor suppressor gene p53: mechanisms of action in cell proliferation and death].
Mendoza-Rodríguez CA; Cerbón MA
Rev Invest Clin; 2001; 53(3):266-73. PubMed ID: 11496714
[TBL] [Abstract][Full Text] [Related]
12. Induction of senescence-like phenotype and loss of paclitaxel sensitivity after wild-type p53 gene transfection of p53-null human non-small cell lung cancer H358 cells.
Ling YH; Zou Y; Perez-Soler R
Anticancer Res; 2000; 20(2A):693-702. PubMed ID: 10810342
[TBL] [Abstract][Full Text] [Related]
13. Does p53 affect organismal aging?
Donehower LA
J Cell Physiol; 2002 Jul; 192(1):23-33. PubMed ID: 12115733
[TBL] [Abstract][Full Text] [Related]
14. Differentiation induced by RB expression and apoptosis induced by p53 expression in an osteosarcoma cell line.
Ookawa K; Tsuchida S; Adachi J; Yokota J
Oncogene; 1997 Mar; 14(12):1389-96. PubMed ID: 9136982
[TBL] [Abstract][Full Text] [Related]
15. Insights into aging obtained from p53 mutant mouse models.
Dumble M; Gatza C; Tyner S; Venkatachalam S; Donehower LA
Ann N Y Acad Sci; 2004 Jun; 1019():171-7. PubMed ID: 15247009
[TBL] [Abstract][Full Text] [Related]
16. p53 mutation heterogeneity in cancer.
Soussi T; Lozano G
Biochem Biophys Res Commun; 2005 Jun; 331(3):834-42. PubMed ID: 15865939
[TBL] [Abstract][Full Text] [Related]
17. Influence of p53 and caspase 3 activity on cell death and senescence in response to methotrexate in the breast tumor cell.
Hattangadi DK; DeMasters GA; Walker TD; Jones KR; Di X; Newsham IF; Gewirtz DA
Biochem Pharmacol; 2004 Nov; 68(9):1699-708. PubMed ID: 15450935
[TBL] [Abstract][Full Text] [Related]
18. [Cell cycle regulation after exposure to ionizing radiation].
Teyssier F; Bay JO; Dionet C; Verrelle P
Bull Cancer; 1999 Apr; 86(4):345-57. PubMed ID: 10341340
[TBL] [Abstract][Full Text] [Related]
19. Targeted point mutations of p53 lead to dominant-negative inhibition of wild-type p53 function.
de Vries A; Flores ER; Miranda B; Hsieh HM; van Oostrom CT; Sage J; Jacks T
Proc Natl Acad Sci U S A; 2002 Mar; 99(5):2948-53. PubMed ID: 11867759
[TBL] [Abstract][Full Text] [Related]
20. p53-dependent gene profiling for reactive oxygen species after benzene inhalation: special reference to genes associated with cell cycle regulation.
Hirabayashi Y
Chem Biol Interact; 2005 May; 153-154():165-70. PubMed ID: 15935813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
